BUZZ-BrightSpring Health slips as KKR carves stake in $435 mln secondary offering

Reuters
Oct 21, 2025
BUZZ-<a href="https://laohu8.com/S/BTSG">BrightSpring Health</a> slips as KKR carves stake in $435 mln secondary offering

** Shares of BrightSpring Health Services BTSG.O down 1.7% premarket at $29.96 after $435 mln overnight secondary offering priced

** Home healthcare and hospice provider late Mon said certain holders including affiliates of KKR KKR.N and members of management parted ways with 15 mln shares

** Offering priced at $29, per thefly.com reports, which is 4.8% discount to stock's last close of $30.47

** In addition, BTSG to concurrently repurchase 1.5 mln of the offering's shares from the underwriter

** Private equity firm KKR offloaded ~14.7 mln shares, and including the repurchase, reduces its stake to ~34.7%, while CEO Jon Rousseau sold 235,000 shares, per the prospectus

** Louisville, Kentucky-based BTSG had ~181 mln shares outstanding as of Oct 17, per the filing

** BofA is sole bookrunner for offering

** BTSG late Mon reported preliminary Q3 results and boosted annual rev guidance to $12.4-$12.7 bln, up from prior outlook of $12.2-$12.6 bln

** BTSG shares were added to S&P SmallCap 600 index .SPCY before the bell on Mon

** Through Mon, stock up 79% in 2025

** 11 of 12 analysts rate stock "strong buy" or "buy", 1 rates "hold" and median PT is $31.50, per LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10